Fuke Qianjin Tablets
A Chinese patent medicine for labeled damp-heat and blood-stasis gynecologic patterns
- Brand
- Qianjin
- China Approval No.
- Z43020027
- Dosage Form
- Tablet
- Individual package
- 0.32 g × 108 tablets
$68.00
- Verified by AuthHerbQuality you can trust
- Brand confirmedQianjin
- Verified AuthenticityProduct authenticity checked
- Evidence & ResearchTraditional use + modern studies
- Authentic packaging matchedAs shown in photos
- Expert supportProduct guidance available
TRUSTED STORE
AUTHHERB-authherb.com
AUTHHERB store has earned the following certifications.
Overview
Medically reviewed by Dr. Xiaoyu Last reviewed: September 5, 2026
Fuke Qianjin Tablets (妇科千金片) is a Chinese patent medicine manufactured by Zhuzhou Qianjin Pharmaceutical Co., Ltd. The official manufacturer describes the product for damp-heat with blood-stasis patterns associated with vaginal discharge and lower-abdominal pain, including chronic pelvic inflammatory disease when that pattern is present.
| Chinese name | 妇科千金片 |
|---|---|
| Pinyin | Fuke Qianjin Pian |
| Brand | Qianjin |
| China Drug Approval No. | Z43020027 |
| Dosage form | tablet |
| Traditional function | Clears heat and dampness, supports qi, and resolves blood stasis. |
| Strength | 0.32 g per tablet |
| Individual package | 0.32 g × 108 tablets |
| Recommended use | Traditionally labeled for vaginal discharge or abdominal pain associated with damp-heat and blood stasis, including chronic pelvic inflammatory disease when the stated pattern is present. |
| GTIN | 6926924500638 |
Main ingredients: Qianjinba root, Jinyinggen root, Common Andrographis Herb, Mahonia stem, Danmianzhen, Chinese Angelica, Suberect Spatholobus Stem, Pilose Asiabell Root
Evidence at a Glance
Systematic reviews of Chinese trials have mainly evaluated Fuke Qianjin tablets as an adjunct to conventional treatment. Pooled results favored combination therapy, but weak or unclear randomization and blinding, China-only evidence, and limited safety reporting substantially restrict confidence.
Do not use during pregnancy or if allergic to this product or any of its ingredients.
Uses
Common Uses
People may consider Fuke Qianjin Tablets for unusual vaginal discharge or lower-abdominal pain, including when these concerns occur with chronic pelvic inflammatory disease.
Traditional & Labeled Uses
清热除湿,益气化瘀
Clears heat and dampness, supports qi, and resolves blood stasis
- Vaginal discharge associated with the stated damp-heat and blood-stasis pattern
- Lower-abdominal pain associated with the stated pattern
- Chronic pelvic inflammatory disease when the stated pattern is present
A labeled traditional use does not establish that the product treats every cause of vaginal discharge or pelvic pain, and it does not show that it can replace antimicrobial treatment when an infection is diagnosed.
Understanding the TCM Perspective
Damp-heat, blood stasis, and qi are Traditional Chinese Medicine pattern terms. They are not direct biomedical diagnoses and should not be used to self-diagnose pelvic inflammatory disease, endometritis, or another cause of pelvic symptoms.
Related TCM Patterns
Fuke Qianjin Tablets is an over-the-counter (OTC) medicine in China. The information on this page is intended for product education and should not replace diagnosis or treatment advice from a qualified healthcare professional.
Safety
Pregnancy
Do not use Fuke Qianjin Tablets during pregnancy. Pregnancy was added as a contraindication in the 2019 NMPA-required labeling revision.
Allergy
Do not use this product if you are allergic to Fuke Qianjin Tablets or any listed ingredient. Stop taking it and seek prompt medical care for breathing difficulty, facial swelling, or another suspected serious allergic reaction.
Breastfeeding
Product-specific breastfeeding safety information was not located in the principal accessible labeling sources. Ask a qualified clinician or pharmacist before use while breastfeeding.
Younger Users
The accessible label-based source advises adolescents to use the product only under a physician’s guidance; it does not establish a product-specific pediatric dose.
Drug Interactions
Specific clinically established interaction data were not identified. The accessible label-based source advises people taking other medicines to consult a physician or pharmacist before use.
When to Seek Medical Advice
Seek medical assessment for red or bloody discharge, severe or worsening abdominal pain, fever, suspected pregnancy, or symptoms that have not improved after two weeks. Stop the product and seek care if an adverse or allergic reaction occurs.
Contraindications
- Do not use during pregnancy.
- Do not use if allergic to this product or any of its ingredients.
Reported Adverse Reactions
- Nausea, vomiting, abdominal pain, diarrhea, abdominal bloating, reduced appetite, dry mouth, constipation, or belching
- Rash or itching
- Dizziness, headache, or vertigo
- Chest pain, insomnia, drowsiness, allergic or allergy-like reactions, palpitations, flushing, breathing difficulty, or swelling
Evidence
Human Clinical Evidence
A 2021 meta-analysis included 125 reported randomized trials involving 14,494 participants with acute or chronic pelvic inflammatory disease or endometritis. Most interventions added Fuke Qianjin tablets to conventional treatment, and pooled composite outcomes favored combination therapy. A 2020 systematic review included 23 trials and 2,527 women comparing Fuke Qianjin plus guideline antibiotic regimens with antibiotics alone; pooled results also favored adjunctive treatment for reported response, lower-abdominal pain, and recurrence outcomes.
Verification
PRODUCT IDENTITY
- Brand Name
- Qianjin
- Chinese Name
- 千金
- Manufacturer
- Zhuzhou Qianjin Pharmaceutical Co., Ltd.
- China drug approval number
- Z43020027
- Prescription status in China
- Over-the-counter medicine.
These are Chinese product-registration details. They do not establish approval or availability in another country.
Verified by the AuthHerb Verification Team
- Brand relationship confirmed
- Manufacturer legal name confirmed
- Approval number confirmed
- Current packaging matched
- Registration holder / manufacturer checked
- Authenticity method checked
- Label/source evidence recorded
Ingredients
This product contains the following ingredients:
- Qianjinba root — 千斤拔
- Jinyinggen root — 金樱根
- Common Andrographis Herb — 穿心莲
- Mahonia stem — 功劳木
- Danmianzhen — 单面针
- Chinese angelica root — 当归
- Suberect Spatholobus stem — 鸡血藤
- Pilose Asiabell Root — 党参
Official Label Dosage
Take 6 tablets orally, 3 times daily.
Follow the current package insert if its instructions differ.
Individual package: 0.32 g × 108 tablets
Missed Dose Information
No product-specific missed-dose instructions were located; no independent missed-dose recommendation is provided.
Additional Directions
The accessible label-based source advises medical assessment if symptoms have not improved after two weeks; it does not define a longer product-specific treatment course for this package.
The 2019 NMPA-required labeling revision advises taking the product after food. Follow the current package leaflet and professional advice.
A purchase option’s quantity does not define how long you should take the medicine.
Frequently Asked Questions About Fuke Qianjin Tablets
They are traditionally labeled for vaginal discharge and lower-abdominal pain associated with a damp-heat and blood-stasis pattern, including chronic pelvic inflammatory disease when that pattern is present. The pattern description is not a biomedical diagnosis.
No. They are a multi-ingredient Chinese patent medicine. Research has often evaluated them alongside antibiotics, which does not make the tablets an antibiotic or a substitute for prescribed antimicrobial treatment.
The available evidence does not justify that claim. Much of the research evaluated Fuke Qianjin as an adjunct to conventional therapy and had important risks of bias and reporting limitations.
No. Pregnancy is listed as a contraindication.
The accessible product information states 6 tablets by mouth, 3 times daily. Follow the current package leaflet and professional advice.
Post-marketing labeling revisions list gastrointestinal symptoms, rash or itching, dizziness or headache, sleep-related symptoms, palpitations, flushing, breathing difficulty, swelling, and allergic or allergy-like reactions. Stop use and seek medical advice for a concerning reaction.
They are related formulations but have different dosage forms and approval numbers. Evidence must be interpreted according to the formulation studied, and capsule research is not direct SKU-level proof for this tablet package.
References
Selected Research
-
[1]Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fuke Qianjin Tabletmeta_analysisEvidence-Based Complementary and Alternative Medicine · 2021
Pan J, Zuo KN, Wang XM, Zhang MP, Wang ZH, Zhang HX, Zhu WT. Systematic Review and Meta-Analysis of Randomized Controlled Trials of Fuke Qianjin Tablet. Evidence-Based Complementary and Alternative Medicine. 2021;2021:8861631.
Study type: meta_analysis
PMID: 33680066
DOI: 10.1155/2021/8861631
-
[2]Fuke Qianjin Combined with Antibiotic Therapy for Pelvic Inflammatory Diseasemeta_analysisEvidence-Based Complementary and Alternative Medicine · 2020
Chen Y, Wei S, Huang L, Luo M, Wu Y, Yin C. Fuke Qianjin Combined with Antibiotic Therapy for Pelvic Inflammatory Disease: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine. 2020;2020:5372839.
Study type: meta_analysis
PMID: 32774421
DOI: 10.1155/2020/5372839
-
[3]Effect of Fuke Qianjin tablets on pharmacokinetics of azithromycin in rats with chronic pelvic inflammatory diseaseanimal_studyZhongguo Zhong Yao Za Zhi · 2016
Li W, Zou L, Gong Y, Zhang P, Wang P, Zhang Y, Qiu L. Effect of Fuke Qianjin tablets on pharmacokinetics of azithromycin in rats with chronic pelvic inflammatory disease. Zhongguo Zhong Yao Za Zhi. 2016;41(12):2339-2343.
Study type: animal_study
PMID: 28901082
